Skip to main content
Home
FULL MENU Close Menu
Home
Home

Nick Mulcahy

News

Bladder cancer indication withdrawn for durvalumab

Author:
Nick Mulcahy
Publish date: March 1, 2021

AstraZeneca has withdrawn durvalumab’s indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit...

  • Read More

News

Obesity ‘clearly’ not tied to worse survival in metastatic breast cancer

Author:
Nick Mulcahy
Publish date: February 1, 2021

For the first time, a large multicenter study explores the effects of obesity on outcomes among patients with...

  • Read More

News

Case study: Maternal cervical cancer linked to neonate lung cancer

Author:
Nick Mulcahy
Publish date: January 15, 2021

Researchers report two cases of lung cancer transmitted via the birth canal from mothers with cervical cancer.

  • Read More

News

After 48 years, NCI aims to track breast cancer recurrences

Author:
Nick Mulcahy
Publish date: January 8, 2021

Breast cancer recurrence is greatly feared among survivors, for obvious reasons, but the National Cancer...

  • Read More

News

‘Contrary’ to wide belief, abscopal effect is rare in cancer

Author:
Nick Mulcahy
Publish date: January 7, 2021

The abscopal effect, whereby tumors are reduced or eliminated even though they are situated outside the radiation field, was first described in...

  • Read More

News

FDA OKs first oral hormone therapy for advanced prostate cancer

Author:
Nick Mulcahy
Publish date: December 18, 2020

Relugolix is an oral form of androgen deprivation therapy.

  • Read More

News

CTCs predict overall survival in metastatic breast cancer

Author:
Nick Mulcahy
Publish date: December 9, 2020

New data seem to support using circulating tumor cells to assess treatment efficacy in practice, but an expert has doubts.

  • Read More

News

SABCS 2020: What’s hot, including a major chemotherapy trial

Author:
Nick Mulcahy
Publish date: December 7, 2020

The world’s largest breast cancer meeting starts on Dec. 8.

  • Read More

News

Testicular cancer link to below-the-waist scans, x-rays?

Author:
Nick Mulcahy
Publish date: November 13, 2020

A case-control study finds that repeated exposure to diagnostic radiation below the waist is associated with...

  • Read More

News

HHS extends deadline for patient access to your clinical notes

Author:
Nick Mulcahy
Publish date: October 30, 2020

Government cites the COVID-19 pandemic as the reason for the delay.

  • Read More

News

Patients can read your clinical notes starting Nov. 2

Author:
Nick Mulcahy
Publish date: October 22, 2020

“Open notes” mandates immediate patient access to inpatient and outpatient notes and testing and imaging results.

  • Read More

News

NCI may ‘kill’ major mammography trial, says adviser

Author:
Nick Mulcahy
Publish date: September 24, 2020

An advisory group to the National Cancer Institute is reviewing the “feasibility and relevance” of the ongoing...

  • Read More

News

Hair dye and cancer study ‘offers some reassurance’

Author:
Nick Mulcahy
Publish date: September 4, 2020

The largest study of its kind found that, with the exception of breast and ovarian cancers, there is no tie...

  • Read More

News

ASCO says ‘no’ to home infusions of cancer treatment, with exceptions

Author:
Nick Mulcahy
Publish date: August 5, 2020

The American Society of Clinical Oncology has warned against intravenous infusion of chemotherapy and monoclonal antibodies in cancer patients’...

  • Read More

News

FDA approves triple drug combo for melanoma

Author:
Nick Mulcahy
Publish date: July 31, 2020

Atezolizumab plus cobimetinib and vemurafenib is now approved for BRAF V600mutation-positive advanced melanoma...

  • Read More

Pages

  • 1
  • 2
  • 3
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close